tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Scott Henry, 85 are a BUY (85.86%), 14 are a HOLD (14.14%).
Analyst Scott Henry, currently employed at ALLIANCE GLOBAL PARTNERS, carries an average stock price target met ratio of 49.8% that have a potential upside of 39.65% achieved within 153 days. Previously, Scott Henry worked at ROTH.
Scott Henry’s has documented 186 price targets and ratings displayed on 30 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on VVOS, Vivos Therapeutics at 19-Nov-2024.
Analyst best performing recommendations are on INVO (INVO BIOSCIENCE).
The best stock recommendation documented was for LGND (LIGAND PHARMACEUTICALS) at 2/4/2021. The price target of $124.77 was fulfilled within 1 day with a profit of $12.41 (11.04%) receiving and performance score of 110.45.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$86
$20.44 (31.18%)
$86
1 months 15 days ago
(12-May-2025)
6/10 (60%)
$23.7 (38.04%)
343
Buy
$94
$28.44 (43.38%)
$94
3 months 10 days ago
(17-Mar-2025)
4/13 (30.77%)
$29.65 (46.08%)
148
Hold
$62
$-3.56 (-5.43%)
$60
8 months 5 days ago
(22-Oct-2024)
8/9 (88.89%)
$1.92 (3.20%)
396
Buy
$83
$17.44 (26.60%)
$49
9 months 9 days ago
(18-Sep-2024)
10/12 (83.33%)
$21.95 (35.95%)
474
Hold
$42
$-23.56 (-35.94%)
$40
2 years 1 months 19 days ago
(08-May-2023)
2/3 (66.67%)
$-0.58 (-1.36%)
274
What Year was the first public recommendation made by Scott Henry?
